ViroVet NV

Tweet this page
<
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 13 Feb 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

10,000€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

0.5 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    ViroVet NV   (ViroVet)

    EU Transparency Register

    984380024354-62 First registered on 07 Nov 2016

    Goals / Remit

    ViroVet is a pioneering company dedicated to the development of disruptive and innovative technologies for the control of viral diseases in livestock, with antiviral drugs for respiratory disease complexes and innovative vaccines for viral infections in swine leading the pipeline. The strategy of ViroVet is to provide novel solutions to be used alone or in combination with vaccines and biosecurity measures in order to provide livestock producers, national governments and international organizations with a multi-faceted arsenal of virus control weapons against endemic and epizootic viral diseases.

    It is clear that with the growing world population there is an increased demand for more protein-rich diets. With the increasing density of the livestock industry, the intensifying global trade and climate changes, there is an ever increased risk for the global spread of viral diseases, severely damaging livestock industry.

    ViroVet has already enlisted the support of a number of k (...)

    Main EU files targeted

    ViroVet monitores everything linked to viral diseases in livestock and in particular epizootic and zoonotic outbreaks

    Address

    Head Office
    Ambachtenlaan 1
    Heverlee 3001
    BELGIUM
    EU Office
    Ambachtenlaan 1
    Heverlee 3001
    BELGIUM

    Website

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%2

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    Support for additional work on African Swine Fever and associated stockpiling of emergency-use product to stop and control outbreaks was anticipated, this would increase the working time to at least 3 FTE at 75%. To date the subsidy request to prepare for an ASF outbreak in Europe was denied, new approaches will be considered to continue our work on antiviral agents to block the disease and reduce the impact of a potential outbreak.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    FlandersBio (www.flanders.bio) and FlandersVaccines as part of FlandersBio

    Leuven Mindgate (www.leuvenmindgate.be)

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    10,000€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    0€ - 10,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    None

    Other activities

    Dr Vytenis Andriukaitis requested ViroVet to contact the commission in the second half of 2016 to start a dialogue on how technologies currently in development at ViroVet could assist the European Commission in preventing and/or controlling outbreaks of viral diseases like African Swine Fever, Food-and-mouth Disease, Rift Valley Fever, Peste des Petits Ruminents, etcetera. Since the outbreak of ASF in Belgium in September 2018, contacts with the European Commission may be reactivated.

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 08 Dec 2016 Location Brussels
      Subject African Swine Fever
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Marco Valletta (Cabinet member)
Download this datacard